Published in Lancet on August 10, 1968
Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. Br Med J (1975) 2.06
Platelet aggregation during oral contraception. Br Med J (1969) 1.63
Platelet alpha-adrenoceptors--a valid model for brain or vascular adrenoceptors? Br J Clin Pharmacol (1986) 1.12
Involuntary movements in patients taking oral contraceptives. Br Med J (1969) 0.96
Metabolic effects of oestrogen treatment in patients with carcinoma of prostate: a comparison of stilboestrol and conjugated equine oestrogens. Br Med J (1973) 0.87
Thrombosis and inhibition of lactation. Br Med J (1968) 0.75
Platelet function: a review. II. Abnormal function. Can Med Assoc J (1970) 0.75
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet (1988) 10.64
Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18
The end of clinical freedom. Br Med J (Clin Res Ed) (1983) 6.27
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology (1974) 4.32
A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12
Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK. Lancet (1988) 4.07
Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet (1988) 4.01
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89
Interim discharge summaries: how are they best delivered to general practitioners? Br Med J (Clin Res Ed) (1987) 3.64
Menopausal flushing: does oestrogen therapy make sense? Lancet (1976) 3.47
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet (1993) 3.43
Self-poisoning: management of patients in Nottingham, 1976. Br Med J (1978) 3.24
Audit of coronary angiography and bypass surgery. Lancet (1990) 3.17
Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation (2000) 2.90
Open access. BMJ (1995) 2.76
Comparison of results from a cardiac ambulance manned by medical or non-medical personnel. Lancet (1977) 2.75
Do women with acute myocardial infarction receive the same treatment as men? BMJ (1994) 2.70
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet (1990) 2.70
Follow-up of emergency ambulance calls in Nottingham: implications for coronary ambulance servie. Br Med J (1975) 2.66
Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62
Accumulation and elimination of poliovirus by the eastern oyster. Am J Epidemiol (1966) 2.58
Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) (1986) 2.55
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53
Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J (1992) 2.46
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation (1993) 2.42
Randomised trial of a mobile coronary care unit for emergency calls. Br Med J (1978) 2.35
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med (1976) 2.33
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32
Prognosis of patients with "chest pain ?cause". Br Med J (Clin Res Ed) (1981) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
RNA binding domain of telomerase reverse transcriptase. Mol Cell Biol (2001) 2.27
Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature (1965) 2.19
Is nursing any business of doctors? A simple guide to the "nursing process". Br Med J (Clin Res Ed) (1984) 2.17
Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11
Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ (1997) 2.08
Mode of referral to hospital of patients with heart attacks: relevance to home care and special ambulance services. Br Med J (1976) 2.04
Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus. Diabetes (1978) 2.04
Isoniazid-associated hepatitis in 114 patients. Gastroenterology (1975) 2.02
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Advanced training for ambulance crews: implications from 403 consecutive patients with cardiac arrest managed by crews with simple training. Br Med J (Clin Res Ed) (1987) 1.92
Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol (1991) 1.91
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J (1995) 1.90
Presentation and analysis of the results of clinical trials in cardiovascular disease. Br Med J (Clin Res Ed) (1981) 1.86
Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation (1996) 1.86
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85
Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet (1985) 1.84
Diagnostic criteria for myocardial infarction. Br J Hosp Med (1981) 1.82
An association between abo blood-group distribution and geographical differences in death-rates. Lancet (1977) 1.81
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int J Cardiol (1993) 1.80
Effect of dipyridamole on human platelet behaviour. Lancet (1965) 1.79
Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther (1983) 1.79
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Resuscitation from out-of-hospital cardiac arrest: is survival dependent on who is available at the scene? Heart (1999) 1.76
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75
Simple training programme for ambulance personnel in the management of cardiac arrest in the community. Br Med J (Clin Res Ed) (1985) 1.74
Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis. Mol Pharmacol (1976) 1.73
Dexamethasone in acute stroke. Br Med J (1978) 1.73
Neurological presentation of bacterial endocarditis. Br Med J (1967) 1.70
Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70
Is an information booklet for patients leaving hospital helpful and useful? BMJ (1989) 1.68
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67
What constitutes evidence on the dietary prevention of coronary heart disease? Cosy beliefs or harsh facts? Int J Cardiol (1984) 1.66
High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med (1992) 1.66
Differences in drug treatment of chronic heart failure between European countries. Eur Heart J (1999) 1.63
Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet (1988) 1.62
The National Service Framework for coronary heart disease: the emperor's new clothes. J R Coll Physicians Lond (2000) 1.60
The role of the interview in student selection. S Afr Med J (1978) 1.59
Autumn Books: Who needs Clinical Pharmacology? Br Med J (Clin Res Ed) (1984) 1.57
Comparison of mortality of patients with heart attacks admitted to a coronary care unit and an ordinary medical ward. Br Med J (1977) 1.57
"But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk. Br Med J (Clin Res Ed) (1982) 1.55
Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia (2000) 1.54
Prevention and diagnosis of venous thrombosis in patients with hip fractures. A survey of current practice. Lancet (1976) 1.52
The health of the nation's research and development. BMJ (1993) 1.52
Blood pressure reduction in elderly: a randomised controlled trial of methyldopa. Br Med J (Clin Res Ed) (1981) 1.52
Diabetic impotence: studies of nocturnal erection during REM sleep. Br Med J (1979) 1.50
Variations in the use of coronary arteriography in the UK: the RITA trial coronary arteriogram register. QJM (1995) 1.47
Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J (Clin Res Ed) (1988) 1.47
Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress. Methods Enzymol (1990) 1.46
Patients' and general practitioners' satisfaction with information given on discharge from hospital: audit of a new information card. BMJ (1989) 1.45
Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology (1974) 1.43
Progress in hepatology. Metabolic activation of drugs to toxic substances. Gastroenterology (1975) 1.42
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction. Br Med J (1979) 1.41
The limited potential of special ambulance services in the management of cardiac arrest. Br Heart J (1990) 1.39
Captopril therapy for heart failure. A placebo controlled study. Lancet (1982) 1.39
Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest (1988) 1.38